Additional file 1 of Antibody targeting tumor-derived soluble NKG2D ligand sMIC reprograms NK cell homeostatic survival and function and enhances melanoma response to PDL1 blockade therapy

Fahmin Basher (Contributor)
Payal Dhar (Contributor)
Xin Wang (Creator)
Derek A. Wainwright (Creator)
Bin Zhang (Creator)
Jeffrey Alan Sosman (Creator)
Zhe Ji (Creator)
Jennifer Donglan Wu (Creator)

Dataset

Description

Additional file 1. Supplement Material and Methods. Table S1, Figures S1-S5.

Date made available	2020
Publisher	figshare

DOI
10.6084/m9.figshare.12456779.v1

Access Dataset

Creative Commons Attribution 4.0 International

1 Article

Antibody targeting tumor-derived soluble NKG2D ligand sMIC reprograms NK cell homeostatic survival and function and enhances melanoma response to PDL1 blockade therapy
Basher, F., Dhar, P., Wang, X., Wainwright, D. A., Zhang, B., Sosman, J., Ji, Z. & Wu, J. D., Jun 9 2020, In: Journal of Hematology and Oncology. 13, 1, 74.
Research output: Contribution to journal › Article › peer-review

Open Access
12 Scopus citations

Cite this

Basher, F. (Contributor), Dhar, P. (Contributor), Wang, X. (Creator), Wainwright, D. A. (Creator), Zhang, B. (Creator), Sosman, J. (Creator), Ji, Z. (Creator), Wu, J. D. (Creator) (2020). Additional file 1 of Antibody targeting tumor-derived soluble NKG2D ligand sMIC reprograms NK cell homeostatic survival and function and enhances melanoma response to PDL1 blockade therapy. figshare. 10.6084/m9.figshare.12456779.v1

Additional file 1 of Antibody targeting tumor-derived soluble NKG2D ligand sMIC reprograms NK cell homeostatic survival and function and enhances melanoma response to PDL1 blockade therapy

Description

DOI

Access Dataset

Research output

Antibody targeting tumor-derived soluble NKG2D ligand sMIC reprograms NK cell homeostatic survival and function and enhances melanoma response to PDL1 blockade therapy

Cite this